The SVP-Chief Accounting Officer of Danaher Corp (NYSE: DHR) is Buying Shares

By Carrie Williams

Today, the SVP-Chief Accounting Officer of Danaher Corp (NYSE: DHR), Robert S. Lutz, bought shares of DHR for $54.13K.

This is Lutz’s first Buy trade following 17 Sell transactions. Following Robert S. Lutz’s last DHR Buy transaction on October 25, 2017, the stock climbed by 10.3%.

See today’s analyst top recommended stocks >>

Based on Danaher Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $4.7 billion and quarterly net profit of $567 million. In comparison, last year the company earned revenue of $4.21 billion and had a net profit of $506 million. DHR’s market cap is $70.34B and the company has a P/E ratio of 27.89. Currently, Danaher Corp has an average volume of 1.44M.

25 different firms, including Argus Research and B.Riley FBR, currently also have a Buy rating on the stock. Based on 6 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $110.17, reflecting a -8.5% downside.

In the last 30 days, insiders have sold $21.97M worth of DHR shares and purchased $1.37M worth of DHR shares. The insider sentiment on Danaher Corp has been negative according to 74 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Robert S. Lutz’s trades have generated a -13.4% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.